Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review
Por:
Altuna, M, Ruiz, I, Zelaya, MV, Mendioroz, M
Publicada:
1 abr 2022
Resumen:
Prion diseases are progressive and irreversible neurodegenerative disorders with a low incidence (1.5-2 cases per million per year). Genetic (10-15%), acquired (anecdotal) and sporadic (85%) forms of the disease have been described. The clinical spectrum of prion diseases is very varied, although the most common symptoms are rapidly progressive dementia, cerebellar ataxia and myoclonus. Mean life expectancy from the onset of symptoms is 6 months. There are currently diagnostic criteria based on clinical phenotype, as well as neuroimaging biomarkers (magnetic resonance imaging), neurophysiological tests (electroencephalogram and polysomnogram), and cerebrospinal fluid biomarkers (14-3-3 protein and real-time quaking-induced conversion (RT-QuIC)). The sensitivity and specificity of some of these tests (electroencephalogram and 14-3-3 protein) is under debate and the applicability of other tests, such as RT-QuIC, is not universal. However, the usefulness of these biomarkers beyond the most frequent prion disease, sporadic Creutzfeldt-Jakob disease, remains unclear. Therefore, research is being carried out on new, more efficient cerebrospinal fluid biomarkers (total tau, ratio total tau/phosphorylated tau and neurofilament light chain) and potential blood biomarkers (neurofilament light chain, among others) to try to universalize access to early diagnosis in the case of prion diseases.
Filiaciones:
Altuna, M:
Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu & St Pau, St Pau Memory Unit, Barcelona 08041, Spain
Ctr Biomed Invest Network Neurodegenerat Dis CIBE, Madrid 28031, Spain
CITA Alzheimer Fdn, Donostia San Sebastian 20009, Spain
Ruiz, I:
Hosp Univ Navarra, Dept Pathol Anat, Pamplona 31008, Spain
Zelaya, MV:
Hosp Univ Navarra, Dept Pathol Anat, Pamplona 31008, Spain
Mendioroz, M:
Hosp Univ Navarra, Dept Neurol, Pamplona 31008, Spain
Univ Publ Navarra UPNA, IdiSNA Navarra Inst Hlth Res, Hosp Univ Navarra, Neuroepigenet Lab Navarrabiomed, Pamplona 31006, Spain
Green Published, gold, All Open Access, Gold, Green
|